Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Philip J. Mease(University of Washington Medical Center), Bernard S. Goffe, James M. Metz, Ann VanderStoep, Barbara Finck, Daniel Burge

The Lancet

July 1, 2000

10.1016/s0140-6736(00)02530-7

Cited by 1,464

Abstract

Related Papers

Severe Psoriasis – Oral Therapy with a New Retinoid

T Fredriksson, U. Pettersson|Dermatologica|2009|2.7k

Etanercept Therapy in Rheumatoid Arthritis

Larry W. Moreland, Michael H. Schiff, Scott W. Baumgartner et al.|Annals of Internal Medicine|1999|1.4k

Treatment of Psoriasis

Malcolm W. Greaves, Gerald D. Weinstein|New England Journal of Medicine|1995|520

Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions

Parisa Ettehadi, M.W. Greaves, David Wallach et al.|Clinical & Experimental Immunology|1994|485

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

Daniel O. Clegg, Domenic J. Reda, Edwin Mejías et al.|Arthritis & Rheumatism|1996|445